Journal of Physiology and Pathophysiology
Subscribe to JPAP
Full Name*
Email Address*

Article Number - 1C78FC1616

Vol.4(2), pp. 23-28 , March 2013

ISSN: 2141-260X

 Total Views: 0
 Downloaded: 0

Full Length Research Paper

A research analysis on blood component usage and wastage in blood bank and blood component center

Manmohan Singhal1*, Manish Patel2, Devesh Kapoor3 and Dalal Mittal4


1School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India.

2Dr Dayaram Patel Pharmacy College, Bardoli, Surat, Gujrat, India.

3College of Healthcare and Allied Sciences, MJRP University, Jaipur, Rajasthan, India.

4ROFEL, Shri GM Bilakhia College of Pharmacy, Vapi, Gujarat, India.

Email: [email protected]

 Accepted: 03 January 2013  Published: 31 March 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0



A comparative analysis of blood component usage and wastage was performed in the Nukem Blood Bank and Rotary Suzlon Blood Component Center, Haria L. G. Rotary Hospital (Vapi) during 2007 and 2008. Reasons for wastage of blood components and trends for reducing blood component wastage were analyzed. Questions about the reasons for wastage and the methods for reducing such wastage were created to help the staff of the blood bank to improve utilization of blood. The collection and utilization of blood and its components had a tendency to increase from 2007 to 2008. A great degree of variation in the percent wastage was found, particularly in the Rh -ve blood type, leading to increase of non availability as well as discarded due to expiry. The most frequent reason for wastage was breakage and red blood cells (RBC) contamination (for fresh frozen plasma (FFP)) and expiry (for PC and packed red blood cell (pRBCs)). The most encountered reasons for utilization were anemia, thrombocytopenia (especially for platelet concentrate (PC)), surgery, accidental injury and hepatitis (especially FFP). Blood and its components are very important resources due to shortage. A proper inventory management system and up gradation of facilities and training of staff is necessary to ensure optimum utilization and minimize wastage.


Key words: Blood, hematocrit, packed red blood cells, transfusion, Nukem blood bank.



Abdul-Rahman IS (2009). Renal disease in hematological malignancies. Hong Kong J. Nephrol. 13(1):5-18.
Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Herve P (2002). Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 42(10):1356-1364.
Blajchman MA, Goldman M, Baeza F (2004). Improving the bacteriological safety of platelet transfusions. Transfus. Med. Rev. 18(1):11-24.
Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA (1991). Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. Transfusion 31:4-11.
Donahue JG, Munoz A, Ness PM (1992). The declining risk of post-transfusion hepatitis C virus infection. N. Engl. J. Med. 327:369–373.
Goodnough LT, Bach RG (2001). Aneamia transfusion and mortality. N. Engl. J. Med. 345:1272-1274.
Hebert PC, wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999). A multicenter, randomized, controlled clinical trial of transfusion requirement in critical care. N. Engl. J. Med. 340:409-417.
Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL (2003). Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematol. 2003:575-589.
Lackritz EM, Satten GA, Aberle-Grasse J (1995). Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N. Engl. J. Med. 333:1721-1725.
Morduchowicz G, Pitlik SD, Huminer D, Alkan M, Drucker M, Rosenfeld JB, Block CS (1991). Transfusion reactions due to bacterial contamination of blood and blood products. Rev. Infect. Dis. 13:307-314.
Ranganathan S, Sesikeran S, Gupta V, Vanajakshi (2008). Emergency therapeutic leukapheresis in a case of acute myeloid leukemia M5. Asian J. Transfus. Sci. 2(1):18-19.
PMid:20041073 PMCid:PMC2798757
Rubin RJ, Ness PM (1989). What price progress? An update on vinyl plastic blood bags. Transfusion 29(4):358-361.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996). The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334:1685-1690.
Sazama K (1990). Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 30:583-590.
Wagner SJ (2004). Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang. 86(3):157-163.


APA (2013). A research analysis on blood component usage and wastage in blood bank and blood component center. Journal of Physiology and Pathophysiology, 4(2), 23-28.
Chicago Manmohan Singhal, Manish Patel, Devesh Kapoor and Dalal Mittal. "A research analysis on blood component usage and wastage in blood bank and blood component center." Journal of Physiology and Pathophysiology 4, no. 2 (2013): 23-28.
MLA Manmohan Singhal, et al. "A research analysis on blood component usage and wastage in blood bank and blood component center." Journal of Physiology and Pathophysiology 4.2 (2013): 23-28.

Subscription Form